Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transfer Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112266364A reveals a metal-free hydrogenation method for tetrahydroquinoxalines using organic catalysts, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Novel non-hydrogenation route for 2'-hydroxydihydrochalcone using 2-phenyl-benzothiazoline. Safe, scalable, cost-effective API intermediate manufacturing.
Patent CN111943950A details a safer, one-pot synthesis for Relebactam intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Patent CN103539596A enables safe formic acid hydrogen transfer for amine synthesis. Offers cost reduction and supply chain reliability for global chemical manufacturers.
Patent CN106831549B details a novel asymmetric transfer hydrogenation route for Carbinoxamine. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN114349687B reveals metal-free asymmetric hydrogenation. Enhances safety and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Novel one-step iridium-catalyzed method for fluorine-containing secondary amines using stable fluorinated alcohols, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Novel atmospheric pressure method for lubiprostone using triethylsilane. Reduces equipment costs and improves purity for pharmaceutical manufacturing.
Patent CN105001159A enables chiral phosphoric acid catalysis for quinoline-3-amine hydrogenation. Delivers high ee values and scalable pharmaceutical intermediate manufacturing solutions.
Novel argatroban synthesis using formic acid transfer hydrogenation ensures safety and cost reduction for pharmaceutical supply chains globally.
Discover a novel debenzylation process for Posaconazole using ammonium formate. Enhanced purity, safety, and cost-efficiency for pharmaceutical manufacturing.
Patent CN114539328B reveals surfactant-promoted route enhancing yield and purity. Delivers supply chain stability and cost efficiency for global buyers.
Patent CN111793017A details a safe ruthenium-catalyzed transfer hydrogenation method for high-ee lactams, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN113999084A details a novel asymmetric synthesis of (S)-nicotine via myosmine reduction, offering high purity and cost-effective manufacturing for reliable suppliers.
Analysis of patent CN103819418A reveals a safer, high-purity synthesis route for Carfentrazone-ethyl intermediates, offering significant cost reduction and supply chain stability for agrochemical manufacturers.
Patent CN109096329B details a novel asymmetric transfer hydrogenation for chiral beta-hydroxy phosphates, offering cost-effective routes for pharmaceutical intermediates.
Patent CN113636968B details a novel ruthenium-catalyzed route for 3-acylpyrroles, offering superior atom economy and simplified purification for pharmaceutical manufacturing.
Patent CN113999201A details a novel asymmetric synthesis of S-nicotine, offering high purity and cost efficiency for pharmaceutical intermediate manufacturing.